Most anesthesia groups distribute all available cash to physician owners annually, which means there is rarely a meaningful balance sheet to value. The equity conversation is really a compensation and control conversation. Here is how to structure it so the group does not fragment when a partner retires.
Key Takeaways
- Most independent anesthesia groups distribute all available cash annually to physician owners, leaving minimal retained earnings. This means there is rarely a balance sheet to value – the buy-in conversation is really about paying for the right to future income streams, not for existing assets.
- A buy-in that is set too high discourages recruitment of younger anesthesiologists into partnership. A buy-in set too low undervalues the income stream the new partner is acquiring. The number should be built from a model of projected distributions, not from historical cost or arbitrary precedent.
- Succession failure is the most common governance crisis in independent anesthesia groups: a senior partner retires or departs without a funded buy-out, a clear equity transfer mechanism, or a replacement credentialed and ramped on the hospital’s medical staff. Plan the transition before it is urgent.
- Groups that have not reviewed their shareholder or partnership agreement in more than five years should do so before a partner transition is imminent. Key provisions – buy-sell triggers, non-compete terms, income continuation on disability, hospital contract assignment rights – often reflect a regulatory and market environment that no longer exists.
Independent anesthesia groups face a structural governance challenge that is more acute than in most physician specialties: the practice’s value is almost entirely forward-looking. Unlike a surgical or procedural group that owns equipment, real estate, or a block of established patients, a hospital-based anesthesia group owns its hospital contract, its provider panel, and the relationships that sustain both. Distribute all available cash to partners every year – which most anesthesia groups do, because there is no compelling reason not to – and there is nothing on a balance sheet for a departing partner to sell or a new partner to buy into. The equity conversation is not really about equity at all. It is about paying for the right to participate in future income, and about allocating the risk that the income stream continues.
That structure creates specific governance vulnerabilities. When a senior partner retires, there is no capital to fund a buy-out. When a group recruits a new physician, there is no balance sheet to reference for a buy-in price. When a hospital demands renegotiation, the group’s ability to respond depends entirely on whether the partnership agreement gives leadership authority to act without requiring unanimous consent. These are the governance failures that end independent anesthesia groups – not slowly, but suddenly, when a transition event arrives before the documents are ready for it.
Setting the Buy-In: What the Number Should Represent
The buy-in is the new partner’s payment for the right to participate in the group’s future income stream on equal terms with existing partners. Because there are rarely hard assets to price, the buy-in is effectively a discounted value of the premium – the difference between what the new partner will earn as a full partner versus what they would earn as a non-partner employee or independent contractor, capitalized over the expected tenure until retirement and discounted for risk.
In practice, most groups set buy-in amounts using one of three approaches. Some charge a flat amount based on what founding partners paid, without reference to current earnings – the most common approach and the most likely to be wrong: an amount set in 2010 bears no relationship to the income stream being purchased in 2026. Some charge a share of the group’s trailing twelve months of net income, which is anchored to something real but applies a simple multiple rather than a present-value model. The defensible approach is a projection model: expected distribution for a new partner over three to five years, discounted for the probability the hospital contract renews and the CRNA cost structure holds, adjusted for what anesthesiologist employment in your region would pay as the alternative.
A buy-in that is too high tells the next generation of anesthesiologists that partnership is not worth it. A buy-in that is too low tells the departing generation that their years of building the group were worth nothing. The right number requires a model, not a tradition.
Distribution Policy and Its Governance Implications
The distribution policy is a governance document as much as a financial one. Equal distributions regardless of production are common in anesthesia groups because the care team model does not easily attribute production to a specific physician. But equal distribution with unequal administrative burden – where two partners carry all of the hospital relationship management, credentialing oversight, and scheduling administration – creates resentment that is one bad contract cycle away from a group split.
Groups operating on informal understandings will not survive a genuine dispute. The governance documents should specify: the formula for dividing distributions (equal, equal with an administrative premium, or production-adjusted), the timing and mechanism (monthly versus quarterly versus annual), the reserve policy, and the process for amending the formula as circumstances change. These provisions should also address what happens during a leave – disability, parental leave, sabbatical – when a partner’s production drops while the group’s costs do not.
The Buy-Sell Agreement: Preparing for Transitions Before They Happen
The buy-sell agreement is the document that governs what happens when a partner wants to leave, is forced to leave, retires, becomes disabled, or dies. In a group that distributes all cash annually, the buy-sell must address a fundamental problem: there is no accumulated capital to fund the buy-out. The options are few but important to choose in advance:
- Installment buy-out. The departing partner is paid over a defined period from the group’s future income, essentially remaining a creditor of the group after departure. This preserves group cash flow but creates an ongoing obligation that can strain operations if multiple partners depart in a short period.
- Life and disability insurance-funded buy-out. The group carries cross-purchase or entity-purchase policies sized to the buy-out obligation. Premium cost is real, but so is the risk that a partner dies without a funded exit mechanism and the group faces an estate claim for a value nobody agreed on.
- Income continuation as buy-out. The departing partner receives a defined income continuation period – paid as if still working while transitioning out. Common in groups where the buy-in was modest and the exit is understood as a graceful transition rather than a capital event.
- No formal buy-out. Partners stop receiving distributions on departure. This works when buy-in was minimal and the arrangement was understood from the start. It creates problems when long-tenured partners who built the group receive nothing while new partners who paid market buy-ins have a different expectation.
Hospital Contract Assignment and Succession Risk
One of the most overlooked succession risks in anesthesia group governance is the hospital contract assignment clause. Most exclusive anesthesia contracts include provisions that limit or restrict the group’s ability to transfer the contract in connection with a change of control, merger, or material change in group composition. If your group loses two of its five founding physicians to retirement within the same contract year, and the hospital’s legal team reads that as a change in the character of the contracting entity, the hospital may have the right to renegotiate or terminate the exclusive contract without waiting for the renewal date.
Groups planning for senior partner retirements in the next three to five years need to review the assignment and change-of-control provisions in the hospital contract alongside the partnership succession plan. A succession plan that transfers equity and hospital privileges on a defined timeline should not run into a hospital contract that defines “material change in group composition” more broadly than the group anticipated. Raise this with the hospital administrator before the transition is underway, not after the retirement date is announced.
From the Field
A four-physician anesthesia group in the Northeast had operated under an informal partnership structure for over a decade, with no written buy-sell agreement and a buy-in amount that had not been updated since the group’s third partner joined nine years earlier. When the senior partner announced a retirement date 18 months out, the remaining partners discovered they had no funded buy-out mechanism, no agreement on the buy-in amount for a replacement physician, and a hospital contract that had a change-of-control provision none of them had read. Rather than deliver a governance memo, our fractional COO engagement worked with the group’s attorney through the buy-sell drafting process – building the distribution model, modeling the installment buy-out cash flow against the group’s trailing revenue, and identifying the hospital contract provision that required a notification letter to the administration before the senior partner’s retirement date. We also built the onboarding timeline for the replacement anesthesiologist, including credentialing milestones that had to be hit for the new provider to be billing before the departure, and worked with the group’s administrator through the credentialing process. The senior partner retired on schedule. The group did not lose its exclusive contract. The replacement physician cleared credentialing three months before the departure date.
When to Consult and When to Engage a Fractional Executive
Governance documents – the operating agreement, the buy-sell, the distribution policy – are legal deliverables. A healthcare attorney drafts them, and a consultant can provide the financial model and the governance framework that the attorney translates into binding language. If your group has a managing partner with the time and interest to drive that process, engaging a consultant to build the model and brief the attorney is often the most efficient approach, and for groups with straightforward partnership structures, it is likely the right choice.
The fractional engagement becomes relevant when governance overlaps with operational execution: when the buy-in model needs to be connected to a recruitment search already underway, when the succession timeline intersects with a hospital contract renewal, or when partners have different views on the distribution formula and someone needs to facilitate the conversation rather than just document it. Whether your situation requires that level of engagement or a well-scoped consulting deliverable depends more on your group’s internal capacity than on the complexity of the governance questions. Both are legitimate choices. What is not a legitimate choice is deferring the work until a transition event forces it. Every independent anesthesia group with partners who will retire in the next decade should have a funded buy-out mechanism, an updated buy-in model, and a partnership agreement reviewed by counsel in the last five years. That work takes months to complete properly and years to undo when it is done wrong under pressure.
Sources
- Anesthesia Resources, Anesthesia Group Mergers, Acquisitions and Alternatives — https://anesres.com/practice-management/anesthesia-group-mergers-acquisitions-and-alternatives/
- Duffy E, Green S, Trish E. Stipends From Hospitals To Emergency Medicine And Anesthesiology Clinicians Increased In California, 2002-21. Health Affairs. 2024. — https://www.healthaffairs.org/doi/10.1377/hlthaff.2024.01220
- CMS, CY 2026 Physician Fee Schedule Final Rule – Anesthesia Conversion Factor ($20.4976) — https://www.cms.gov/medicare/payment/fee-schedules/physician/anesthesiologists-center
- 42 CFR 415.110 – Conditions for payment: Medically directed anesthesia services (TEFRA rules) — https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-415/subpart-C/section-415.110
More in the Anesthesiology Series
- Negotiating the Hospital Stipend with Data — how to build the cost-gap analysis that supports a defensible stipend request.
- Care Team Model Economics: What the Staffing Ratio Actually Costs — how to model the real cost of each anesthesia staffing configuration before you commit to one.
- Anesthesia Billing: Base Units, Time Units, and the Modifiers That Matter — the billing mechanics that determine whether your group collects what it earned.
- Anesthesia Payer Contracting and the No Surprises Act IDR Process — how to negotiate commercial rates and use the IDR process when payers refuse to move.